Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study
العنوان: | Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study |
---|---|
المؤلفون: | Lena Borsa, Bettina Petersen, Pablo Mora, Christopher G. Parkin, Maureen R. Lyden, Ann Buskirk |
المصدر: | Diabetes Technology & Therapeutics |
بيانات النشر: | Mary Ann Liebert, Inc., 2017. |
سنة النشر: | 2017 |
مصطلحات موضوعية: | Adult, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Patient satisfaction, Diabetes management, Diabetes mellitus, Internal medicine, medicine, Diabetes Mellitus, Insulin, Humans, Hypoglycemic Agents, Telemetry, 030212 general & internal medicine, Prospective Studies, Glycemic, Aged, Glycated Hemoglobin, Type 1 diabetes, business.industry, Remote Consultation, Original Articles, Multiple daily injections, Middle Aged, medicine.disease, Medical Laboratory Technology, Distress, chemistry, mHealth, Patient Satisfaction, Physical therapy, Self-monitoring of blood glucose, Female, Glycated hemoglobin, business |
الوصف: | Background: The ability to automatically transfer data to clinicians and receive timely guidance in therapy adjustments through remote and in-office consults can positively impact patients' perceptions about quality of care, which is positively associated with clinical outcomes. We assessed the impact of using the Accu-Chek Connect diabetes management system on treatment satisfaction, diabetes distress, and glycemic control in adults with type 1 diabetes and insulin-treated type 2 diabetes. Subjects and Methods: This 6-month, prospective, multicenter, single-arm study assessed the impact of using the system on treatment satisfaction and glycemic control among 87 adults with insulin-treated diabetes (multiple daily insulin injections and basal only), with 8.8% ± 1.6% glycated hemoglobin (HbA1c) at baseline. The Diabetes Treatment Satisfaction Questionnaire-status (DTSQs) and Diabetes Distress Scale (DDS) were administered at baseline, and the Diabetes Treatment Satisfaction Questionnaire-change (DTSQc) and DDS at 6 months. Changes in HbA1c, average blood glucose (BG), and other metrics were also assessed. Results: Improvements in DTSQc scores were observed at 6 months with a total mean (standard deviation) score of 14.3 ± 5.1. Significant reductions in total mean DDS scores from baseline to 6 months were also observed, from 2.0 ± 0.8 to 1.7 ± 0.7, P |
اللغة: | English |
تدمد: | 1557-8593 1520-9156 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6754512f6083662e71c107d83034b42Test http://europepmc.org/articles/PMC5734194Test |
حقوق: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....c6754512f6083662e71c107d83034b42 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15578593 15209156 |
---|